United States Court of Appeals Fifth Circuit, 600, Camp Street, Central Business District, French Quarter, New Orleans, Orleans Parish, Louisiana, 70130, United StatesNasdaq
已确认可信度 83%The en banc opinion in No. 21-60626 is stamped "FILED December 11, 2024" and "Date Filed: 12/11/2024".[1]
The full US Court of Appeals for the Fifth Circuit voted 9-8 to vacate the SEC's approval of Nasdaq's rule requiring listed companies to have a woman and a minority or LGBTQ+ director on the board or explain why not.
已确认可信度 87%The FDA[1][5] drug safety communication carries the entry "12-16-2024 Update: FDA adds a Boxed Warning, our most prominent warning, to highlight the known risk of rare but serious liver injury".
The FDA adds a boxed warning, its most prominent, to Astellas' hot-flash pill Veozah after a patient suffered serious liver injury within about 40 days of starting it, and orders monthly liver tests for the first months.